Carregant...

Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease

PURPOSE: Characterize the safety and tolerability of lifitegrast ophthalmic solution 5.0% for the treatment of dry eye disease. METHODS: Pooled data from five randomized controlled trials were analyzed. Key inclusion criteria were adults with dry eye disease (Schirmer tear test score ⩾1 and ⩽10 mm,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Ophthalmol
Autors principals: Nichols, Kelly K, Donnenfeld, Eric D, Karpecki, Paul M, Hovanesian, John A, Raychaudhuri, Aparna, Shojaei, Amir, Zhang, Steven
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6625033/
https://ncbi.nlm.nih.gov/pubmed/30112930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1120672118791936
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!